• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Sorrento Therapeutics, Inc. (SRNE)

    -NasdaqCM
    8.48 Up 0.32(3.92%) 4:00PM EST
    Add to Portfolio
    Prev Close:8.16
    Open:8.35
    Bid:7.01 x 600
    Ask:8.46 x 1000
    1y Target Est:17.00
    Beta:4.51
    Next Earnings Date:N/A
    Day's Range:7.95 - 8.50
    52wk Range:3.10 - 16.40
    Volume:864,046
    Avg Vol (3m):182,600
    Market Cap:245.34M
    P/E (ttm):N/A
    EPS (ttm):-1.54
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for SRNE

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):75.47
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.28
    Quarterly EPS Est (Dec-14) :-0.27
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Sorrento Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary drug therapeutics for addressing unmet medical needs in the United States, Europe, and internation... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback